Market research
LOTUSEYE.NSE Lotus Eye Hospital and Institute Limited
NSE INR Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2B
- P/E ratio
- 1419.5
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.52
Profile
Instrument facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- INE947I01017
- Market cap
- 2B
- P/E ratio
- 1419.5
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.52
About
About Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch-free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive errors, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and corneal infections, as well as various eye-related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
Research context
Lotus Eye Hospital and Institute Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the LOTUSEYE.NSE discussion.
5 years, 6 months ago
Lotus Eye Hospital and Institute Limited is currently in a long term uptrend where the price is trading 29.0% above its 200 day moving average.
From a valuation standpoint, the stock is 37.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.
Lotus Eye Hospital and Institute Limited's total revenue sank by 1.6% to $99M since the same quarter in the previous year.
Its net income has increased by 540.4% to $11M since the same quarter in the previous year.
Finally, its free cash flow fell by 118.2% to $-3M since the same quarter in the previous year.
Based on the above factors, Lotus Eye Hospital and Institute Limited gets an overall score of 3/5.